Study of lymph nodes during lung surgery for early lung cancer
Part of Cancer, Lungs & breathing clinical trials.
This study looks at certain lymph nodes removed during surgery for non-small cell lung cancer (NSCLC) that has grown into the covering of the lung. The goal is to better understand lymph node involvement and help guide future treatment decisions.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have NSCLC that can be removed completely with surgery
- Your tumor is under 3 cm and you had a lobectomy, bilobectomy, or segmentectomy
- Surgery included taking lymph nodes from stations 12, 13, and 14
- Surgery also included removing lymph nodes from stations 10 and 11 near the lung’s main airways/blood vessels
- Your surgeon was able to remove all visible cancer with clear margins (R0 resection)
- You have never had lung cancer before, and you do not have cancer that has spread (no M1)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at molecular (biologic) signals in the tumor and nearby lymph nodes after curative surgery for stage IIIA lung cancer. It may help doctors better understand the disease and improve future treatment planning.
This trial studies a better way to remove and examine lymph nodes from lung cancer surgery specimens. It aims to improve how doctors check for cancer spread, which may help guide your treatment after surgery.
This trial tests whether a more focused lymph node removal during surgery is safe and effective for people with a small, early-stage lung cancer (non-small cell type) located in the top part of the lung (apical segment).
This trial compares two ways of doing lung cancer surgery for early-stage tumors in the left lung. Some participants will have more lymph nodes removed (station 4L) and others will not, to see if the extra removal helps prevent the cancer from coming back.
This study tests a new way to decide which lymph nodes to remove during lung cancer surgery. The goal is to make surgery more precise and reduce side effects while still effectively removing cancer.
This study looks at whether removing lymph nodes from the opposite side of the chest during surgery can help people with advanced lung cancer that has spread to the lymph nodes in the middle of the chest. It may offer a more thorough treatment for patients who are healthy enough for surgery.
Hear when a new Lung cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.